During the past decade, Central Coast Neurosciences Research conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Coast Neurosciences Research" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Anavex Life Sciences Corp." with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Actinogen Medical" with 1 trials sponsored and "Apellis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Coast Neurosciences Research" #1 collaborator was "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator, "Anavex Canada Ltd." with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Central Coast Neurosciences Research" are "Alzheimer Disease" (6 trials), "Alzheimer's Disease" (4 trials), "Cardiovascular Disease" (2 trials), "Amyotrophic Lateral Sclerosis" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "Central Coast Neurosciences Research" in a lesser frequency.

Most popular intervention types in "Central Coast Neurosciences Research" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Gantenerumab" (2 trials), "bococizumab (PF-04950615)" (2 trials), "ANAVEX2-73" (1 trials) and "ATH-1017" (1 trials). Other intervention names were less common.

The vast majority of trials in "Central Coast Neurosciences Research" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Central Coast Neurosciences Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Central Coast Neurosciences Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Central Coast Neurosciences Research, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Central Coast Neurosciences Research has several departments that took part in Clinical trials: "Central Coast Neuroscience Research" - 2 trials